Invasive Aspergillosis as an Under-recognized Superinfection in COVID-19

George R Thompson Iii1,2, Oliver A Cornely3,4,5,6, Peter G Pappas7

  • 1Department of Internal Medicine, University of California Davis Medical Center, Davis, California, USA.

Insights

Pulmonary aspergillosis is a growing concern after severe respiratory viral infections like COVID-19. Early identification of COVID-19 associated pulmonary aspergillosis (CAPA) is crucial for better patient outcomes.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Pulmonology

Background:

  • Pulmonary aspergillosis incidence rises after severe respiratory viral infections.
  • Millions infected with SARS-CoV-2 are at risk for COVID-19 associated pulmonary aspergillosis (CAPA).

Purpose of the Study:

  • To highlight the increasing association between SARS-CoV-2 and pulmonary aspergillosis.
  • To emphasize the critical need for prompt recognition of CAPA.

Main Methods:

  • Review of recent clinical reports and epidemiological data.
  • Analysis of risk factors and clinical presentation of CAPA.

Main Results:

  • Significant increase in reported cases of pulmonary aspergillosis post-SARS-CoV-2 infection.
  • CAPA identified as a serious complication in COVID-19 patients.

Conclusions:

  • Early diagnosis and management of CAPA are essential.
  • Increased vigilance for fungal co-infections in respiratory viral pandemics is warranted.

Related Concept Videos

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
2.2K
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
5.2K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
677
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
669
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
591
Infection01:20

Infection

When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
11.3K